# A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

> **NCT06249919** · PHASE1,PHASE2 · RECRUITING · sponsor: **Neuracle Science Co., LTD.** · enrollment: 138 (estimated)

## Conditions studied

- Seneorineural Deafness
- Sudden Sensorineural Hearing Loss

## Interventions

- **BIOLOGICAL:** NS101
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06249919
- **Lead sponsor:** Neuracle Science Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-19
- **Primary completion:** 2026-05-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06249919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06249919, "A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06249919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*